Vitamin D deficiency in obese patients with Type 2 diabetes
Introduction: Vitamin D deficiency is involved in the pathogenesis of insulin resistance, which is the main factor in the development of type 2 diabetes. In Poland, a high percentage of people with vitamin D deficiency is observed, as well as incidences of type 2 diabetes. In 2013, recommendations r...
| Published in: | Journal of Education, Health and Sport |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
Kazimierz Wielki University
2018-09-01
|
| Subjects: | |
| Online Access: | https://apcz.umk.pl/JEHS/article/view/25806 |
| _version_ | 1852642531817291776 |
|---|---|
| author | Aneta Szafraniec Dominik Porada Beata Matyjaszek-Matuszek |
| author_facet | Aneta Szafraniec Dominik Porada Beata Matyjaszek-Matuszek |
| author_sort | Aneta Szafraniec |
| collection | DOAJ |
| container_title | Journal of Education, Health and Sport |
| description | Introduction: Vitamin D deficiency is involved in the pathogenesis of insulin resistance, which is the main factor in the development of type 2 diabetes. In Poland, a high percentage of people with vitamin D deficiency is observed, as well as incidences of type 2 diabetes. In 2013, recommendations regarding vitamin D supplementation for Central Europe inhabitants were published, which recommend the use of vitamin D preparations for obese people with a dose of 600-4000 IU / per Day
Purpose of the work: Evaluation of the prevalence of vitamin D deficiency in obese patients with chronically decompensated type 2 diabetes mellitus and appropriate supplementation in accordance with given recommendations.
Material and metod: Evaluation of laboratory tests and applied pharmacotherapy in 40 patients with chronically decompensated type 2 diabetes, aged from 38 to 89 years old.
Results: In the experimental group the average concentration of 25 (OH) D3 was 20.3 ng / ml ± 11.7. Supplementation of vitamin D preparations was used by 15% of patients. Only 22.5% of patients had correct concentrations of 25 (OH) D3, but only one person used vitamin D supplements in this group.
Conclusions: One in five obese patients with type 2 diabetes have normal levels of vitamin D. Among obese diabetics nearly 90% of patients do not apply the recommendations for vitamin D supplementation. Knowledge about the benefits of vitamin D supplementation should be widely propagated among diabetologists and general practitioners. |
| format | Article |
| id | doaj-art-fa98887f4f0f4da49df8158fdcc76fca |
| institution | Directory of Open Access Journals |
| issn | 2391-8306 |
| language | English |
| publishDate | 2018-09-01 |
| publisher | Kazimierz Wielki University |
| record_format | Article |
| spelling | doaj-art-fa98887f4f0f4da49df8158fdcc76fca2025-08-19T21:44:12ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062018-09-0189Vitamin D deficiency in obese patients with Type 2 diabetesAneta Szafraniec0Dominik Porada1Beata Matyjaszek-Matuszek2Chair and Department of Endocrinology, Medical University of LublinChair and Department of Endocrinology, Medical University of LublinChair and Department of Endocrinology, Medical University of LublinIntroduction: Vitamin D deficiency is involved in the pathogenesis of insulin resistance, which is the main factor in the development of type 2 diabetes. In Poland, a high percentage of people with vitamin D deficiency is observed, as well as incidences of type 2 diabetes. In 2013, recommendations regarding vitamin D supplementation for Central Europe inhabitants were published, which recommend the use of vitamin D preparations for obese people with a dose of 600-4000 IU / per Day Purpose of the work: Evaluation of the prevalence of vitamin D deficiency in obese patients with chronically decompensated type 2 diabetes mellitus and appropriate supplementation in accordance with given recommendations. Material and metod: Evaluation of laboratory tests and applied pharmacotherapy in 40 patients with chronically decompensated type 2 diabetes, aged from 38 to 89 years old. Results: In the experimental group the average concentration of 25 (OH) D3 was 20.3 ng / ml ± 11.7. Supplementation of vitamin D preparations was used by 15% of patients. Only 22.5% of patients had correct concentrations of 25 (OH) D3, but only one person used vitamin D supplements in this group. Conclusions: One in five obese patients with type 2 diabetes have normal levels of vitamin D. Among obese diabetics nearly 90% of patients do not apply the recommendations for vitamin D supplementation. Knowledge about the benefits of vitamin D supplementation should be widely propagated among diabetologists and general practitioners.https://apcz.umk.pl/JEHS/article/view/25806vitamin Dtype 2 diabetes mellitusinsulin resistancecarbohydrate management |
| spellingShingle | Aneta Szafraniec Dominik Porada Beata Matyjaszek-Matuszek Vitamin D deficiency in obese patients with Type 2 diabetes vitamin D type 2 diabetes mellitus insulin resistance carbohydrate management |
| title | Vitamin D deficiency in obese patients with Type 2 diabetes |
| title_full | Vitamin D deficiency in obese patients with Type 2 diabetes |
| title_fullStr | Vitamin D deficiency in obese patients with Type 2 diabetes |
| title_full_unstemmed | Vitamin D deficiency in obese patients with Type 2 diabetes |
| title_short | Vitamin D deficiency in obese patients with Type 2 diabetes |
| title_sort | vitamin d deficiency in obese patients with type 2 diabetes |
| topic | vitamin D type 2 diabetes mellitus insulin resistance carbohydrate management |
| url | https://apcz.umk.pl/JEHS/article/view/25806 |
| work_keys_str_mv | AT anetaszafraniec vitaminddeficiencyinobesepatientswithtype2diabetes AT dominikporada vitaminddeficiencyinobesepatientswithtype2diabetes AT beatamatyjaszekmatuszek vitaminddeficiencyinobesepatientswithtype2diabetes |
